Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and Influenza virus
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and Influenza virus
Authors
Keywords
glucosylceramide, sphingolipids, antiviral drugs, glucosylceramide synthase, COVID-19, SARS-CoV-2
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume -, Issue -, Pages 100470
Publisher
Elsevier BV
Online
2021-02-25
DOI
10.1016/j.jbc.2021.100470
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucosylceramide synthase maintains influenza virus entry and infection
- (2020) Kelly Drews et al. PLoS One
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
- (2020) Natacha S. Ogando et al. JOURNAL OF GENERAL VIROLOGY
- Glucosylceramidase Maintains Influenza Infection By Regulating Endocytosis
- (2019) Kelly Drews et al. JOURNAL OF VIROLOGY
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- (2019) Alan Talevi et al. Expert Opinion on Drug Discovery
- Dynamic remodeling of lipids coincides with dengue virus replication in the midgut of Aedes aegypti mosquitoes
- (2018) Nunya Chotiwan et al. PLoS Pathogens
- Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe
- (2017) Nadia Belmatoug et al. European Journal of Internal Medicine
- A role for glycolipid biosynthesis in severe fever with thrombocytopenia syndrome virus entry
- (2017) Mary Jane Drake et al. PLoS Pathogens
- Induction of the type I interferon response in neurological forms of Gaucher disease
- (2016) Einat B. Vitner et al. Journal of Neuroinflammation
- CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease
- (2016) John Marshall et al. MOLECULAR THERAPY
- Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells
- (2016) Hann Low et al. Cell Reports
- Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases—Not Glycolipid Processing Enzymes
- (2016) Andrew C. Sayce et al. PLoS Neglected Tropical Diseases
- A Lipidomics Approach in the Characterization of Zika-Infected Mosquito Cells: Potential Targets for Breaking the Transmission Cycle
- (2016) Carlos Fernando Odir Rodrigues Melo et al. PLoS One
- Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1
- (2015) Pramod K. Mistry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Eliglustat tartrate
- (2014) J.A. Shayman DRUGS OF THE FUTURE
- Strain-specific antiviral activity of iminosugars against human influenza A viruses
- (2014) S. Hussain et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lipidomics identifies a requirement for peroxisomal function during influenza virus replication
- (2014) Lukas Bahati Tanner et al. JOURNAL OF LIPID RESEARCH
- Modulation of Hepatitis C Virus Genome Replication by Glycosphingolipids and Four-Phosphate Adaptor Protein 2
- (2014) I. Khan et al. JOURNAL OF VIROLOGY
- Sphingolipid lysosomal storage disorders
- (2014) Frances M. Platt NATURE
- Liposome-Mediated Delivery of Iminosugars Enhances Efficacy against Dengue VirusIn Vivo
- (2012) Joanna L. Miller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design, Synthesis, and Biological Evaluation of N-Alkylated Deoxynojirimycin (DNJ) Derivatives for the Treatment of Dengue Virus Infection
- (2012) Wenquan Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease
- (2012) Mario A. Cabrera-Salazar et al. PLoS One
- Inhibitors of Endoplasmic Reticulum α-Glucosidases Potently Suppress Hepatitis C Virus Virion Assembly and Release
- (2010) Xiaowang Qu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Targeting a host process as an antiviral approach against dengue virus
- (2010) Andrew C. Sayce et al. TRENDS IN MICROBIOLOGY
- N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery
- (2008) Stephanie Pollock et al. AIDS
- Influenza Virus Infection Augments NK Cell Inhibition through Reorganization of Major Histocompatibility Complex Class I Proteins
- (2008) H. Achdout et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now